SEC Form 4 · accession 0001179110-16-021613
OSIRIS THERAPEUTICS, INC. · OSIR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Frank D Czworka Jr.
Officer — Vice President
Period of report
Mar 9, 2016
Accepted (ET)
Mar 14, 2016 · 6:53 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001360886
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy)F1 | $5.08 | Mar 9, 2016 | D | 3,750 | A | Mar 23, 2013 | Mar 23, 2022 | Common Stock | 3,750 | 100,000 | D |
| Incentive Stock Option (right to buy)F1 | $7.73 | Mar 9, 2016 | D | 5,000 | A | Feb 12, 2014 | Feb 12, 2023 | Common Stock | 5,000 | 95,000 | D |
| Incentive Stock Option (right to buy)F1 | $15.58 | Mar 9, 2016 | D | 9,430 | A | May 21, 2015 | May 21, 2024 | Common Stock | 9,430 | 85,570 | D |
| Non-Qualified Stock Option (right to buy)F1 | $15.58 | Mar 9, 2016 | D | 13,070 | A | May 21, 2015 | May 21, 2024 | Common Stock | 13,070 | 72,500 | D |
| Non-Qualified Stock Option (right to buy)F1 | $18.40 | Mar 9, 2016 | D | 13,316 | A | Mar 6, 2016 | Mar 6, 2025 | Common Stock | 13,316 | 59,184 | D |
| Incentive Stock Option (right to buy)F1 | $18.40 | Mar 9, 2016 | D | 5,434 | A | Mar 7, 2016 | Mar 6, 2025 | Common Stock | 5,434 | 53,750 | D |
Explanation of responses
- F1Unvested incentive stock option that were forfeited concurrent with the Reporting Person's execution of separation agreement, consistent with the provisions of the Amended and Restated 2006 Omnibus Plan. The Reporting Person's stock options that were vested on the date that he executed the separation agreement will remain exercisable for 90 days from the departure date.